Risk factors associated with loss to follow-up of breast cancer patients: A retrospective analysis
Background: Loss to follow-up (LTFU) during post-operative surveillance of breast cancer patients is detrimental. The pattern of LTFU and its risk factors in Chinese breast cancer patients remains unknown. Method: Eligible non-metastatic breast cancer patients who underwent surgery at our institutio...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-06-01
|
Series: | Breast |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0960977621000266 |
id |
doaj-6458d126a7174016912feee1edaea4c4 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Qian Ouyang Shunrong Li Ming Gao Liling Zhu Shiyun Xu Shunhao Meng Siqiao Wu Liqiu Huang Fengxi Su Zefang Ren Kai Chen Min Peng |
spellingShingle |
Qian Ouyang Shunrong Li Ming Gao Liling Zhu Shiyun Xu Shunhao Meng Siqiao Wu Liqiu Huang Fengxi Su Zefang Ren Kai Chen Min Peng Risk factors associated with loss to follow-up of breast cancer patients: A retrospective analysis Breast Breast cancer Loss to follow-up Surveillance Risk score |
author_facet |
Qian Ouyang Shunrong Li Ming Gao Liling Zhu Shiyun Xu Shunhao Meng Siqiao Wu Liqiu Huang Fengxi Su Zefang Ren Kai Chen Min Peng |
author_sort |
Qian Ouyang |
title |
Risk factors associated with loss to follow-up of breast cancer patients: A retrospective analysis |
title_short |
Risk factors associated with loss to follow-up of breast cancer patients: A retrospective analysis |
title_full |
Risk factors associated with loss to follow-up of breast cancer patients: A retrospective analysis |
title_fullStr |
Risk factors associated with loss to follow-up of breast cancer patients: A retrospective analysis |
title_full_unstemmed |
Risk factors associated with loss to follow-up of breast cancer patients: A retrospective analysis |
title_sort |
risk factors associated with loss to follow-up of breast cancer patients: a retrospective analysis |
publisher |
Elsevier |
series |
Breast |
issn |
1532-3080 |
publishDate |
2021-06-01 |
description |
Background: Loss to follow-up (LTFU) during post-operative surveillance of breast cancer patients is detrimental. The pattern of LTFU and its risk factors in Chinese breast cancer patients remains unknown. Method: Eligible non-metastatic breast cancer patients who underwent surgery at our institution between 2009 and 2012 were included. The clinicopathological features, as well as the LTFU status, were retrieved from the REDCap database. LTFU was defined as the absence of patients for at least 12 months since her last contact. 5-year LTFU was defined as the LTFU status of each patients at 5 years after surgery. The incidence and potential risk factors of LTFU were analyzed. A LTFU-risk score was developed to quantify the risk of LTFU. Results: A total of 1536 patients with breast cancer were included, and 411(26.8%) patients were 5-year LTFU. 198 patients were LTFU in the first year. Univariate and multivariate analysis revealed that age (younger and older), a lack of medical insurance, longer distance from residence to the hospital, pathology (DCIS/Paget’s/Phyllodes), lymph node metastasis, the absence of endocrine therapy and fewer than five contact numbers were significantly and independently associated with the risk of LTFU. A LTFU-risk score was developed and was predictive of LTFU. Conclusions: A series of risk factors were significantly associated with post-operative LTFU of breast cancer patients. Patients with different risks of LTFU could possibly be identified, and surveillance plans could be individualized for different patients, so as to effectively reduce the overall LTFU rate, and optimize the allocation of medical resources. |
topic |
Breast cancer Loss to follow-up Surveillance Risk score |
url |
http://www.sciencedirect.com/science/article/pii/S0960977621000266 |
work_keys_str_mv |
AT qianouyang riskfactorsassociatedwithlosstofollowupofbreastcancerpatientsaretrospectiveanalysis AT shunrongli riskfactorsassociatedwithlosstofollowupofbreastcancerpatientsaretrospectiveanalysis AT minggao riskfactorsassociatedwithlosstofollowupofbreastcancerpatientsaretrospectiveanalysis AT lilingzhu riskfactorsassociatedwithlosstofollowupofbreastcancerpatientsaretrospectiveanalysis AT shiyunxu riskfactorsassociatedwithlosstofollowupofbreastcancerpatientsaretrospectiveanalysis AT shunhaomeng riskfactorsassociatedwithlosstofollowupofbreastcancerpatientsaretrospectiveanalysis AT siqiaowu riskfactorsassociatedwithlosstofollowupofbreastcancerpatientsaretrospectiveanalysis AT liqiuhuang riskfactorsassociatedwithlosstofollowupofbreastcancerpatientsaretrospectiveanalysis AT fengxisu riskfactorsassociatedwithlosstofollowupofbreastcancerpatientsaretrospectiveanalysis AT zefangren riskfactorsassociatedwithlosstofollowupofbreastcancerpatientsaretrospectiveanalysis AT kaichen riskfactorsassociatedwithlosstofollowupofbreastcancerpatientsaretrospectiveanalysis AT minpeng riskfactorsassociatedwithlosstofollowupofbreastcancerpatientsaretrospectiveanalysis |
_version_ |
1721504015718547456 |
spelling |
doaj-6458d126a7174016912feee1edaea4c42021-04-28T06:08:30ZengElsevierBreast1532-30802021-06-01573642Risk factors associated with loss to follow-up of breast cancer patients: A retrospective analysisQian Ouyang0Shunrong Li1Ming Gao2Liling Zhu3Shiyun Xu4Shunhao Meng5Siqiao Wu6Liqiu Huang7Fengxi Su8Zefang Ren9Kai Chen10 Min Peng11Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China; Breast Tumor Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, 510120, PR ChinaGuangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China; Breast Tumor Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, 510120, PR ChinaGuangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China; Department of Radiology, Sun Yat-Sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, 510120, PR ChinaGuangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China; Breast Tumor Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, 510120, PR ChinaGuangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China; Breast Tumor Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, 510120, PR ChinaDisease Registry Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, 510120, PR ChinaDisease Registry Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, 510120, PR ChinaDisease Registry Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, 510120, PR ChinaGuangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China; Breast Tumor Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, 510120, PR ChinaDepartment of Statistics and Epidemiology, School of Public Health, Sun Yat-sen University, Guangzhou, 510080, PR ChinaGuangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China; Breast Tumor Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, 510120, PR China; Corresponding author. Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China.Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China; Breast Tumor Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, 510120, PR China; Disease Registry Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, 510120, PR China; Corresponding author. Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China.Background: Loss to follow-up (LTFU) during post-operative surveillance of breast cancer patients is detrimental. The pattern of LTFU and its risk factors in Chinese breast cancer patients remains unknown. Method: Eligible non-metastatic breast cancer patients who underwent surgery at our institution between 2009 and 2012 were included. The clinicopathological features, as well as the LTFU status, were retrieved from the REDCap database. LTFU was defined as the absence of patients for at least 12 months since her last contact. 5-year LTFU was defined as the LTFU status of each patients at 5 years after surgery. The incidence and potential risk factors of LTFU were analyzed. A LTFU-risk score was developed to quantify the risk of LTFU. Results: A total of 1536 patients with breast cancer were included, and 411(26.8%) patients were 5-year LTFU. 198 patients were LTFU in the first year. Univariate and multivariate analysis revealed that age (younger and older), a lack of medical insurance, longer distance from residence to the hospital, pathology (DCIS/Paget’s/Phyllodes), lymph node metastasis, the absence of endocrine therapy and fewer than five contact numbers were significantly and independently associated with the risk of LTFU. A LTFU-risk score was developed and was predictive of LTFU. Conclusions: A series of risk factors were significantly associated with post-operative LTFU of breast cancer patients. Patients with different risks of LTFU could possibly be identified, and surveillance plans could be individualized for different patients, so as to effectively reduce the overall LTFU rate, and optimize the allocation of medical resources.http://www.sciencedirect.com/science/article/pii/S0960977621000266Breast cancerLoss to follow-upSurveillanceRisk score |